Novartis AG
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Novartis AG in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Novartis AG.
Recent articles on PMLiVE featuring Novartis AG
Approximately half of those with Sjögren’s disease are thought to be undiagnosed
The pharma company has also pledged a $100bn investment in US infrastructure over the next decade
In 2025, the pharma company announced a $23bn US investment commitment
Around 9,000 people in the US currently live with SMA
This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
The US hub is expected to create 700 new jobs by 2030
The treatment demonstrated non-inferiority to current standard of care
The REPLENISH trial met all primary and secondary endpoints, demonstrating sustained remission vs placebo
Patient outcome benefits were observed in two ongoing phase 3 trials
The acquisition will expand Novartis’ neuroscience pipeline
Investing in data analytics and AI tools can lead to smarter clinical trials and faster, more informed decisions
The latest trial results reinforce the drug’s long-term efficacy and safety profile
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology